Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
, 6 (4), 191-196
eCollection

Sexual Dysfunction in Selective Serotonin Reuptake Inhibitors (SSRIs) and Potential Solutions: A Narrative Literature Review

Affiliations

Sexual Dysfunction in Selective Serotonin Reuptake Inhibitors (SSRIs) and Potential Solutions: A Narrative Literature Review

Elizabeth Jing et al. Ment Health Clin.

Abstract

Sexual dysfunction is an underdiscussed adverse effect to selective serotonin reuptake inhibitors (SSRIs) and may increase the risk for discontinuation and nonadherence to antidepressant pharmacotherapy. Given the prevalence of depression, health care providers should educate patients about SSRI-associated sexual dysfunction in order to promote patient awareness and medication adherence. This study evaluated primary literature from 1997 to 2015 to identify SSRI-related sexual side effects, therapeutic alternatives, and treatment strategies. The results indicate that paroxetine is associated with the greatest rate of sexual dysfunction among the SSRIs. Potential alternatives to SSRI treatment include bupropion, mirtazapine, vilazodone, vortioxetine, and serotonin-norepinephrine reuptake inhibitors. In the event that a subject responds solely to SSRIs but experiences unwanted sexual side effects, bupropion may be added as an adjunctive medication. Some limited evidence also suggests that saffron may reduce some aspects of sexual dysfunction, excluding ability to reach orgasm.

Keywords: SSRI; bupropion; citalopram; delayed ejaculation; escitalopram; fluoxetine; mirtazapine; paroxetine; selective serotonin reuptake inhibitors; sertraline; sexual dysfunction; sexual side effect; venlafaxine.

Conflict of interest statement

Disclosures: The authors have nothing to disclose.

Similar articles

See all similar articles

References

    1. Kim WK, Shin D, Song WO. Depression and Its comorbid conditions more serious in women than in men in the United States. J Womens Health (Larchmt). 2015; 24 12: 978- 85. DOI: 10.1089/jwh.2014.4919. PubMed PMID: 26131726. - DOI - PubMed
    1. Olfson M, Marcus SC. National patterns in antidepressant medication treatment. Arch Gen Psychiatry. 2009; 66 8: 848- 56. DOI: 10.1001/archgenpsychiatry.2009.81. PubMed PMID: 19652124. - DOI - PubMed
    1. American Psychiatric Association. Practice guideline for the treatment of patients with major depressive disorder, 3rd ed. Arlington (VA): The Association; 2010.
    1. Rosenber KP, Bleiberg KL, Koscis J, Gross C. A survey of sexual side effects among severely mentally ill patients taking psychotropic medications: impact on compliance. J Sex Marital Ther. 2003; 29 4: 289- 96. PubMed PMID: 14504017. - PubMed
    1. Waldinger MD. Psychiatric disorders and sexual dysfunction. Handb Clin Neurol. 2015; 130: 469- 89. DOI: 10.1016/B978-0-444-63247-0.00027-4. PubMed PMID: 26003261. - DOI - PubMed

LinkOut - more resources

Feedback